MLchartDataset catalogue

CNDO-109-activated allogeneic natural killer cells

Term · Oncology and biomedicine · MLC-T-ONC-012685

A preparation of non-interleukin-2 primed, tumor activated allogeneic natural killer (NK) cells with potential immunostimulating activity. The allogeneic NK cells obtained from a first or second degree relative of the patient are co-incubated with a lysate from the CTV-1 cell line, a minimally differentiated myeloid line derived from an acute myelogenous leukemia patient. Infusion of CNDO-109-activated allogeneic NK cells may be able to lyse and destroy NK-resistant tumor cells and a broad spectrum of tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-012685
FieldOncology and biomedicine
SynonymsCNDO-109-AANK cells
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012685",
  "term": "CNDO-109-activated allogeneic natural killer cells",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of non-interleukin-2 primed, tumor activated allogeneic natural killer (NK) cells with potential immunostimulating activity. The allogeneic NK cells obtained from a first or second degree relative of the patient are co-incubated with a lysate from the CTV-1 cell line, a minimally differentiated myeloid line derived from an acute myelogenous leukemia patient. Infusion of CNDO-109-activated allogeneic NK cells may be able to lyse and destroy NK-resistant tumor cells and a broad spectrum of tumor cells.",
  "synonyms": [
    "CNDO-109-AANK cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/cndo-109-activated-allogeneic-natural-killer-cells/"
}

Record 5,033 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.